Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
×

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Nuvo Research Inc T.NRI

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  NRIFF| NRIFD

Nuvo Research Inc is a specialty pharmaceutical company with manufacturing operations. The Company operates two distinct business units, the Topical Products and Technology (TPT) Group and the Immunology Group.
Price: $5.30 | Change: $-0.10 | %Change: -1.85%
Volume: 11,316 | Day High/Low: 5.35/5.26 | 52 Week High/Low: 10.36/3.50
View modes: 
0 stars

WF10 Success

Its success this year can be viewed much like drilling a successful oil well on a concession that has no conveyance infrastructure.ie temporarily stranded. Lets say the well  tests at 10,000...read more
0 stars

RE:RE:RE:RE:RE:RE:RE:Stalemate Breakdown to the Upside Shortly

Sorry to disagree good man he may be but I think Zars  was his fault, he sold the goods to our unknowing CEO's and BoD on that phenominal waste of money.  rate and reply
1 star

They Droned on and on..

Stop filling this board with your useless rants Nothing but a bunch of Monday morning quarterbacks. Oh, they never get it right do they ? First, it was the right deal but the wrong partner. Now, its...read more
3 stars

RE:RE:RE:RE:RE:RE:Stalemate Breakdown to the Upside Shortly

Reading the facts on this subject, presented in explicit, nauseating detail is outrageous and my bloods been boiling since your initial post. While 15-20 bux (if we even get there) would provide some...read more
5 stars

RE:RE:RE:RE:RE:Stalemate Breakdown to the Upside Shortly

Where are u getting your numbers from ? Good question. The Q2 Report (page 40) under the title Stock Appreciation Rights Plan identifies the outstanding SARS units and their exercise price. Each...read more
0 stars

RE:RE:RE:RE:Stalemate Breakdown to the Upside Shortly

Where are u getting your numbers from ? Sedar shows $297,000 in Sars expense for the first 2 quarters of 2015. Cash flows in Q1 dont show your Sars amount  Sars granted in January was at $7.20...read more
5 stars

RE:RE:RE:RE:Stalemate Breakdown to the Upside Shortly

That is, afterall, why executive compensation is tightly correlated with market cap size. Using that theory Nuvo's executives should be making about 25% of their salary for taking the company...read more
3 stars

RE:RE:RE:Stalemate Breakdown to the Upside Shortly

So, its better to have the share price exit at $4 instead of $20 ? At $20, our market cap will be $220 million vs $40 million at $4. While I could agree on the posit of excess compensation per se, I...read more
3.5 stars

RE:RE:Stalemate Breakdown to the Upside Shortly

Let's say you are right. My own estimate would be around $18/share based on two successful trials in Q4 and certain other structural changes in the BOD occurring in 2015. The company would incurr...read more
0 stars

New presentation August 31th 2015

Number of bottle sold  remain around 7.5k  rate and reply
5 stars

RE:Stalemate Breakdown to the Upside Shortly

Good point. Nuvo began its breakout in late August in 2014, in anticipation of favorable WF10 results. There are other drivers this year, each with  forward temporal weighting to result...read more
0 stars

RE:Study...Why P2 will outsell Voltaren Gel

Interesting that Galer left the employ of Nuvo without any acknowledgment by management - not as much as a press release even though he was a key member of the company's management team...read more
0 stars

Study...Why P2 will outsell Voltaren Gel

Pain Pract. 2011 May-Jun;11(3):252-60. doi: 10.1111/j.1533-2500.2010.00420.x. Epub 2010 Sep 20. A comparative subjective assessment study of PENNSAID® and Voltaren Gel®, two topical...read more
0 stars

Stalemate Breakdown to the Upside Shortly

The low volume we are seeeing is a typical stalemate that occurs before the run up to major events.  Owners of the stock now feel no urgency to sell as the news is in the short term...read more
0 stars

RE:RE:RE:RE:What Does TD Know ?

Whats with you Rambo ? Why dont you buy more PWT..  rate and reply
1 star

RE:RE:RE:What Does TD Know ?

Hey Rock,  what happened ?? The stage was all yours,,, You were given the mic ,,, You had the world all around you to crumbling like a pile of bricks without mortar ,scrambling to find a safe...read more
0 stars

RE:RE:What Does TD Know ?

The pollen season has been very close to that of 2010. Short, intense and nicely successive.....trees, grass and now ragweed. If you believe in statistcal confidence when experiments are conducted...read more
0 stars

RE:What Does TD Know ?

They've simply recognized a sure bet. Worst-case they walk away with a quarter million dollar profit in a few months  rate and reply
0 stars

What Does TD Know ?

Over 400,000 bought recently.. Could it be WF10 trial success?  rate and reply
0 stars

RE:RE:Yahoo post yesterday

This is exactly the point I made as have others. Obscuring real gross margin level is the losses by the Immunology Group which will be no longer part of the earnings after this year. With increasing...read more